Home › Multiple Myeloma › NCT00898235

Collection of Samples and Clinical Data From Patients With Amyloid Diseases

Data, Tissue, Blood, and Urine Repository for Amyloid Diseases

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

DISEASE CHARACTERISTICS:

* Diagnosis or suspicion of amyloidosis

PATIENT CHARACTERISTICS:

* Referred to the Amyloid Treatment and Research Center at Boston University Medical Center

PRIOR CONCURRENT THERAPY:

* Not specified

Exclusion Criteria:

None

About the study

RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future.

PURPOSE: This research study is collecting samples from patients with amyloid diseases

What is being tested

• clonality analysis (genetic)
• polymerase chain reaction (genetic)
• protein analysis (genetic)
• biologic sample preservation procedure (other)
• laboratory biomarker analysis (other)
• fluorescence spectroscopy (procedure)

Sponsor: Boston Medical Center · Participants: 10,000 · Started: 2000-01

Contact the study team

• Vaishali Sanchorawala, MD · Phone: 617-638-8261
• Annie Jose, BS · Phone: 617 638 8213

Official record on ClinicalTrials.gov — NCT00898235

Locations in the U.S.

Conditions

• Multiple Myeloma
• Immunoglobulin Light-chain Amyloidosis

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.